With the presence of a large number of leading market players, the ventricular assist device market in North America is characterized by a highly competitive landscape, states Transparency Market Research (TMR). The high degree of competition can be attributed to the fact that patent expiry of one vendor creates opportunities for other companies. Several market players have been trying to extend their presence in emerging economies. For instance, Voltas Limited has been planning to enter the Middle East via participation in international events such as Qatar Olympics in 2022 and the World Expo in Dubai to be held in 2020.
During 2015, the North America ventricular assist device market was pegged at US$0.4 bn, according to the findings of TMR. The market will keep flourishing at a promising CAGR of 9.20% between 2016 and 2024, achieving a revenue worth US$1.07 bn by the end of 2024.
Robust Technological Growth of the U.S. to Promote Expansion
The U.S. is likely to represent a larger share in the ventricular assist device market in North America compared to Canada. Greater number of device approvals, along with the rapid advancement of science and technology, particularly in the treatment of heart failure, have been driving the market for ventricular assist devices in the U.S. This regional segment is expected to continue to hold its dominance throughout the forecast period as well, owing to higher awareness about these devices amongst patients and healthcare providers.
By indication, the destination therapy (DT) segment is expected to emerge as the leading segment of the ventricular assist device market in North America. This can be attributed to the declining number of heart donors and the increasing use of total abdominal hysterectomy (TAH).
Alarming Incidence of Heart Failure to Impel Adoption
The rising incidence of heart failure amongst the population of North America is a primary growth driver of the market. The American Heart Association found that nearly 16% of the population in the U.S. die from stroke, while a massive 68% of the population above the age of 65 suffering from diabetes die from heart disease. As the most common cause of heart failure is left ventricular dysfunction, leading to congestive heart failure, more number of patients are likely to opt for ventricular assist devices.
Fewer number of heart donors and increasing demand for heart transplants have also been promoting the growth of the market for ventricular assist devices in North America. Moreover, the various awareness campaigns initiated by organizations such as St. Jude Medical are creating awareness about the enhanced quality of life resulting from ventricular assist devices among the patient population.
On the contrary, the high costs of these treatments and the possibility of device malfunction can impede the growth of the market for ventricular assist devices in North America. However, the development of advanced products such as magnetic levitation can ensure steady growth of the market.
The information presented in this review is based on a Transparency Market Research report, titled, “Ventricular Assist Device Market (Product Type - Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Bi-Ventricular Assist Device (Bi-VAD), and Total Artificial Heart (TAH); Indication - Bridge to Transplant (BTT), Destination Therapy (DT), and Bridge to Recovery (BTR)) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
Key segments of the North America Ventricular Assist Device Market
North America Ventricular Assist Device Market, by Product Type
- LVAD (Left ventricular assist device)
- RVAD (Right ventricular assist device)
- Bi-VAD (Biventricular assist device)
- TAH( Total artificial heart)
North America Ventricular Assist Device Market, by Indication
- BTT (Bridge To Transplant)
- DT (Destination Therapy)
- BTR (Bridge To Recovery)
North America Ventricular Assist Device Market, by Geography
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453